Active Shortage

JAMP-METHOTREXATE

JAMP PHARMA CORPORATION

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of JAMP-METHOTREXATE in Canada?

Yes. JAMP-METHOTREXATE 25MG has an active shortage reported to Health Canada (last updated October 7, 2022).

Why is JAMP-METHOTREXATE not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will JAMP-METHOTREXATE be available again?

The estimated resolution date (June 30, 2023) has passed, but the report has not been updated yet. Follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file6 products · 3 same form & route

Affected strength25MG

Report last updated2022-10-07

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

METHOTREXATE INJECTION USP

PFIZER CANADA ULC

25MG · DIN 02182777

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

METHOTREXATE INJECTION BP

ACCORD HEALTHCARE INC

25MG · DIN 02327236

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

METHOTREXATE INJECTION, BP

PHARMASCIENCE INC

25MG · DIN 02422204

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

METOJECT SUBCUTANEOUS

MEDEXUS PHARMACEUTICALS INC.

20MG · DIN 02454866

Different strengthSame dosage formDifferent routeNo current shortage

Compare these two →

METHOFILL SELF-DOSE INJECTOR

ACCORD HEALTHCARE INC

15MG · DIN 02530791

Different strengthSame dosage formDifferent routeNo current shortage

Compare these two →

PMS-METHOTREXATE INJECTION

PHARMASCIENCE INC

10MG · DIN 02539608

Different strengthSame dosage formDifferent routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.

Estimated Resolution

2023-06-30

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02419173

Strength

25MG

Dosage Form

SOLUTION

Route

INTRA-ARTERIAL INTRAMUSCULAR INTRATHECAL INTRAVENOUS

Active Ingredient

METHOTREXATE

Tier

Unrated

Last Updated

2022-10-07

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from JAMP PHARMA CORPORATION

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACTIVATED CHARCOAL

225MG · DIN 02420694

AMIKACIN SULFATE INJECTION

250MG · DIN 02529459

AMIODARONE HYDROCHLORIDE FOR INJECTION

50MG · DIN 02423227

AMLODIPINE

5MG · DIN 02429217

AMLODIPINE

10MG · DIN 02429225

AMLODIPINE

2.5MG · DIN 02492199